$1.35 -0.06 (-4.26%)
2/10/2012 4:00 PM

Novavax, Inc. (NASDAQ:NVAX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

Featured Broker Partners


Advertisement